Healthcare Costs and Resource Use Among Chronic Low-Back Pain Patients Treated With Belbuca or Buprenorphine Transdermal Patches: A Retrospective US Medicare Claims Analysis
Conclusion: This study demonstrated lower total cLBP-related and any-cause outpatient costs with fewer cLBP-related outpatient visits and favorable healthcare cost trends in Belbuca as compared with buprenorphine patch patients.
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | Pain Research and Management |
| Online Access: | http://dx.doi.org/10.1155/prm/1646185 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|